Tanshinone IIA can alleviate HF by promoting the proliferation and differentiation of endogenous liver stem cells (Yang et al., 2020) and inhibiting the TGF-β1/Smad signaling pathway (Xu et al., 2022). The gene discussed is TGFB1; the disease is hydrops fetalis.